GC Pharma getting closer to world’s first commercialized recombinant protein for hepatitis B

Published: 2018-01-19 16:30:00
Updated: 2018-01-19 09:49:38

GC Pharma(CEO Eun-Cheol Huh), formally known as Green Cross, announced on the 18th that the Phase II/III clinical trial plan for ‘GC1102(Hepabig-gene),’ a recombinant immunoglobulin for the treatment of hepatitis B, has acquired approval from the Ministry of Food and Drug Safety.

The hepatitis B...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.